
Licorice Root Extract: Some licorice-derived compounds are studied for uneven pigmentation. Retinaldehyde: Some formulas improve photoaged texture and pigmentation over months.


Consider as an optional pigment ingredient; independent clinical evidence is limited.
Consider for photoaged texture; introduce slowly and judge the complete formula.
Can you use both?
Licorice is soothing and can offset retinaldehyde redness.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.











Contains several active compounds: Glabridin and liquiritin have different actions. May help uneven pigmentation: Extracts and clinical evidence vary.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Converts to retinoic acid: Skin enzymes can activate retinaldehyde. Changes cell activity: Retinoic acid acts through nuclear receptors.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.
Built from where each one usually sits in a routine. Introduce one at a time.
Licorice root extract contains multiple compounds, including liquiritin and glabridin. Whole-extract percentages do not reveal the dose of these individual compounds.
Choosing a strength: Look for the named extract or purified compound and evidence for the finished product.
Higher strengths: There is no established universal percentage range or proof that higher whole-extract concentrations improve pigmentation.
Formula matters: A small study of liquiritin cannot establish a recommended strength for every licorice extract, species, or formulation.
0.05% and 0.1% retinaldehyde creams have been compared in a controlled photoaging trial. These percentages cannot be directly compared with retinol or tretinoin.
0.05%
0.1%
Lower studied retinal strength
A cream studied for skin texture and hydration. The result applies to that finished formula.
Higher studied retinal strength
Also studied for photoaging; not better for every measured outcome. Tolerance still determines whether a product suits you.
Choosing a strength: Choose retinaldehyde for its own formula and instructions, not a retinol-to-retinal conversion chart.
Higher strengths: A higher percentage may be harder to tolerate. Stronger products sold commercially do not automatically have stronger comparative clinical evidence.
Formula matters: Encapsulation, stability and the cream or serum base affect delivery. A percentage alone is not a measure of how much reaches skin cells.
Approximate windows, not promises.
First few weeksAssess tolerance first; pigment change is usually slower.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksSome studied regimens begin showing pigment improvement.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksA useful review point for benefit and irritation.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
Botanical extracts can cause allergy or stinging; check the complete formula.
Dryness, stinging and peeling can occur; avoid irritated areas.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Data are limited; ask the clinician managing your pregnancy.
Retinoids are conventionally stopped in pregnancy and while trying to conceive. Ask the doctor managing your pregnancy. Azelaic acid is the usual alternative.
On the skin. The finished product delivers licorice root extract in a particular vehicle.
Entering skin. No single molecular mass. The 500 Da guideline cannot be applied to this whole ingredient family or mixture.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Compounds such as liquiritin and glabridin have different pigment-related actions; they are not interchangeable extracts.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers retinaldehyde in a particular vehicle.
Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Conversion. Skin can convert retinaldehyde into retinoic acid.
Skin response. Skin can convert retinaldehyde into retinoic acid, which influences cell activity through retinoid receptors.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Consider as an optional pigment ingredient; independent clinical evidence is limited.
A 20-woman split-face study tested a specific liquiritin cream for four weeks with sun protection. It does not establish that all licorice extracts treat melasma or rosacea.
Consider for photoaged texture; introduce slowly and judge the complete formula.
A 40-woman trial compared two active strengths without a retinoid-free vehicle group. It supports cautious formula-specific claims, not guaranteed superiority to retinol or acne medicines.
Sources